Julia Neugebauer
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Julia Neugebauer currently works at Vivoryon Therapeutics NV, as Chief Operating Officer & Executive Director from 2025.
Dr. Neugebauer also formerly worked at MorphoSys AG, as Senior Director-Investor Relations from 2020 to 2022.
Dr. Neugebauer received her doctorate degree from Ludwig-Maximilians-Universität München.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Operationeel Directeur | 01-05-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MORPHOSYS AG | Investor Relations Contact | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau